Duo successfully invalidate two CureVac patents in the UK | High Court deems patents invalid due to lack of inventive step and insufficient technical contribution | CureVac “disappointed” but stressed ...

Value-for-money UPC is worth it says GSK corporate counsel | Court offers alternative to costly US litigation | Head of ...

Roche’s chief trademark officer has more than filing and searches on his to-do list—and external counsel must keep up, he ...

A UK court upholds the patent for Astellas Pharma's life-extending prostate cancer treatment | Judgment dismisses attempts by ...

7 March 2022 Regeneron has failed to convince a Manhattan district court to drop a lawsuit claiming that it developed ...

Alnylam backed down after judge’s patent interpretation favoured Moderna | Case is part of a spate of infringement lawsuits ...

German pharma giant claims Granules India’s ANDA infringes five patents I Combination therapy Jentadueto among Boehringer’s ...

Having been involved in more than 30 cases at the UPC, the Bardehle Pagenberg litigator tells Marisa Woutersen why success at the game-changing court is a team effort. Already registered?

Janssen Biotech denied permission to appeal invalidation of ustekinumab patent | Samsung Bioepis convinced UK court to revoke ...